NKTR

Nektar Therapeutics

Nektar Therapeutics is a leading biopharmaceutical company that specializes in developing innovative medicines to address unmet medical needs. With a focus on cancer, autoimmune diseases, and chronic pain, Nektar's proprietary drug delivery technology platform, PEGylation, enables the development of drugs with improved efficacy, safety, and convenience. The company has a robust pipeline of drug candidates in various stages of development, including NKTR-214, a potential treatment for multiple types of cancer, and NKTR-181, a novel opioid analgesic for chronic pain. Nektar is dedicated to improving the lives of patients through the development of transformative medicines and advancing the field of drug delivery technology.

Instrument specification in OANDA

Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top